Drug or treatment

Nemolizumab clinical trials

• 7Clinical trials
• 6Countries

Newest trials

All recruiting trials (7)

• Nemolizumab vs placebo in Chinese teens and adults with moderate-to-severe atopic dermatitis

  This study tests whether Nemolizumab can help moderate-to-severe atopic dermatitis in Chinese participants aged 12 and up, compared with a placebo.

  Recruiting Phase 3 Galderma R&D · Hangzhou, Zhejiang · NCT07762833

• Skin structure in atopic dermatitis patients treated with nemolizumab assessed by reflectance confocal microscopy

  This study tests whether nemolizumab changes skin structure in adults with moderate-to-severe atopic dermatitis using a noninvasive imaging method.

  Recruiting Hôpitaux Drôme Nord · Romans-sur-Isère, Drôme · NCT07730788

• Nemolizumab for infants with moderate-to-severe atopic dermatitis

  This study tests whether nemolizumab can be safely given to infants aged 6 to under 24 months to help manage moderate-to-severe eczema when topical treatments alone aren’t enough.

  Recruiting Phase 2 Galderma R&D · San Antonio, Texas · NCT07660835

• Nemolizumab for lichen planopilaris

  This will test whether nemolizumab reduces scalp itching and hair loss in adults with lichen planopilaris.

  Recruiting Phase 4 The Skin Center Dermatology Group · New City, New York · NCT07396168

• Nemolizumab for adults with systemic sclerosis

  This trial will test whether nemolizumab can reduce skin thickness in adults with systemic sclerosis over a 52-week treatment period.

  Recruiting at 3 sites Phase 2 Galderma R&D · Ann Arbor, Michigan and 2 other locations · NCT07047690

• Using nemolizumab (Nemluvio) to treat moderate-to-severe prurigo nodularis in adults

  This project tries nemolizumab (Nemluvio) in adults with moderate-to-severe prurigo nodularis to see if it reduces itching and symptoms by six months.

  Recruiting at 49 sites Galderma R&D · Birmingham, Alabama and 50 other locations · NCT06988618

• Nemolizumab for moderate-to-severe atopic dermatitis in adolescents and adults

  This will try nemolizumab in adolescents and adults with moderate-to-severe atopic dermatitis to see if it improves symptoms and patient-reported outcomes over six months.

  Recruiting at 81 sites Galderma R&D · Birmingham, Alabama and 107 other locations · NCT06988605

Quick answers

How many clinical trials of Nemolizumab are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in United States (5 trials), Germany (2 trials), France (1 trial), United Kingdom (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →